Robbins llp reminds investors of the applied therapeutics, inc. (aplt) class action and urges investors with large losses to contact the firm for information

San diego, jan. 02, 2025 (globe newswire) -- robbins llp reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired applied therapeutics, inc. (nasdaq: aplt) securities between january 3, 2024 and december 2, 2024. applied therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases.
APLT Ratings Summary
APLT Quant Ranking